Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
5.91
+0.03 (0.51%)
Nov 14, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $137.37 million as of November 14, 2025. Its market cap has decreased by -17.84% in one year.
Market Cap
137.37M
Enterprise Value
120.44M
1-Year Change
-17.84%
Ranking
Category
Stock Price
$5.91
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $137.37M, a decrease of -9.70%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 137.37M | -11.64% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |